Showing results (21-30 of 280) with videos related to
Sort By:
Pageof 28
Cellular Immunology|March 6, 2019
Emerging roles of and therapeutic strategies targeting BRD4 in cancerMary E White, Joelle M Fenger, William E CarsonCancer Immunology, Immunotherapy : CII|March 11, 2008
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysisLisa M Thornton, Barbara L Andersen, William E CarsonMelanoma Research|July 19, 2018
Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanomaGonzalo N Olaverria Salavaggione, Megan C Duggan, William E CarsonAmerican Journal of Translational Research|August 27, 2013
The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte responseZhenzhen Liu, Jianhua Yu, William E Carson, et al.Surgical Oncology|August 28, 2016
MicroRNA dysregulation in melanomaNicholas Latchana, Akaansha Ganju, J Harrison Howard, et al.Clinical Case Reports|December 20, 2018
Unusual recurrence of breast cancer in a BRCA-variant patient after fat graftingJohn P Skendelas, Clara Lee, Ann Mangino, et al.Alternative Therapies in Health and Medicine|April 21, 2012
Review of complementary and alternative medicine and selected nutraceuticals: background for a pilot study on nutrigenomic intervention in patients with advanced cancerKimberly A Varker, Adam Ansel, Glen Aukerman, et al.Free Radical Biology & Medicine|October 11, 2002
Dermal wound healing properties of redox-active grape seed proanthocyanidinsSavita Khanna, Mika Venojarvi, Sashwati Roy, et al.American Journal of Physiology. Heart and Circulatory Physiology|April 18, 2002
Copper-induced vascular endothelial growth factor expression and wound healingChandan K Sen, Savita Khanna, Mika Venojarvi, et al.Cancer Immunology, Immunotherapy : CII|August 1, 2023
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapySteven H Sun, Colin D Angell, Himanshu Savardekar, et al.Pageof 28